Saic Venture Capital Corp
—- Market cap
- —
- Debt
- —
- Cash
- —
Complete market value, debt and cash evidence is required for enterprise value.
Compare price, profitability, solvency, and SEC-reported financials side by side—before deciding which assumptions deserve a closer look.
FY 2025 · Mkt capMarket cap $76.74B · View financials
Decision snapshot: Saic Venture Capital Corp stock price vs REGN: inconclusive Relative valuation is incomplete for this pair. Review the available filing metrics before drawing a conclusion.
Quick read
Each company valued on the other's multiple, then compared with the market price.
Implied fair value · at REGN's multiple
Needs Annual EPS.
Implied fair value · at Saic Venture Capital Corp's multiple
Needs Saic Venture Capital Corp P/E.
Engine logicSaic Venture Capital Corpvalued onREGN’smultiple
Metric by metric
Snapshot Sep 8, 2026, 1:35 PM ET
Where each company leads, and how wide the gap is.
Higher is better
Pricing power
Operating leverage
Lower is better
Not comparable
Lower leverage
Statements
Core statements aligned to each company's latest fiscal year.
SEC periods: Saic Venture Capital Corp Latest annual filing · REGN FY 2025 (ended Dec 31, 2025). Fiscal years are not aligned.
Trendline
Five fiscal years of revenue, earnings, and margins before underwriting a re-rating.
Price framework
Market cap plus debt, less cash.
Complete market value, debt and cash evidence is required for enterprise value.
Capital structure 97% equity / 3% debt · EV / Revenue 4.89x · EV / EBITDA 12.86x
Price framework
The same filing-backed model used on each company's valuation page, with company-specific inputs and calculated scenarios.
SAIC VENTURE CAPITAL CORP · implied price per share
Reporting currency could not be verified.
REGENERON PHARMACEUTICALS, INC. · implied price per share
Debt and bridge-cash inputs are required to translate enterprise value into equity value.
Balance sheet health
Financial health checks to separate durable balance sheets from potential value traps.
Financial strength on a 0–9 scale.
Saic Venture Capital Corp · not enough data.
Bankruptcy-risk signal from balance sheet and earnings power.
Debt / equity
Total debt against shareholders' equity
—
0.06x
Net debt / EBITDA
Leverage against operating earnings
—
-1.21x
Cash and equivalents
Liquid reserves on the balance sheet
—
$8.61B
Total debt
Interest-bearing obligations outstanding
—
$1.99B
Comparable set
Where the pair sits against the wider comparable set.
Keep comparing
Open adjacent comparisons from the same industry to pressure-test the read across multiple pairs.
AMGEN INC
Saic Venture Capital Corp vs AMGN
PFIZER INC
Saic Venture Capital Corp vs PFE
BRISTOL MYERS SQUIBB CO
Saic Venture Capital Corp vs BMY
BIOGEN INC.
Saic Venture Capital Corp vs BIIB
GILEAD SCIENCES, INC.
Saic Venture Capital Corp vs GILD
Seagate Technology Holdings plc
Saic Venture Capital Corp vs STX
LLM-powered synthesis
An explanation of the financial evidence. Check its snapshot date against the figures above.
The deterministic comparison remains available. Sign in when you want an on-demand narrative synthesis of the same data.